Le Lézard
Classified in: Business, Covid-19 virus
Subject: GOVERNMENT CONTRACTS

FAIR Canada Welcomes OSC Ban on Deferred Sales Charges


TORONTO , May 07, 2021 (GLOBE NEWSWIRE) -- The Canadian Foundation for Advancement of Investor Rights (FAIR Canada) applauds the announcement from the Ontario Securities Commission (OSC) indicating that it will ban deferred sales charges (DSC) on mutual funds in Ontario, anticipated to take effect on June 1, 2022.

"This is a huge win for investors in Ontario," said Jean-Paul Bureaud, FAIR Canada's Executive Director. "We are very pleased to see that Ontario will be joining the rest of Canada in banning these charges. Not only will this reduce investor confusion, but it will eliminate a fee structure that has long been recognized as creating a conflict of interest between investors and their advisors."

FAIR Canada has advocated for a nation-wide ban on DSCs for many years. The ban will protect investors from being locked-in to funds that may be performing poorly, freeing up their investments to cover unforeseen expenses without worrying about redemption charges. This will be especially important to support the economic recovery out of the COVID-19 pandemic. We need to do all we can to help Canadians who are struggling to try to rebuild their retirement savings.

About FAIR Canada

FAIR Canada is a national, independent charitable organization dedicated to being a catalyst for the advancement of the rights of investors and financial consumers in Canada. As the voice of the Canadian investor and financial consumer, FAIR Canada advances its mission through outreach and education, public policy submissions to governments and regulators, proactive identification of emerging issues and other initiatives. FAIR Canada has a reputation for independence, thought leadership in public policy and moving the needle in the interests of retail investors and financial consumers.

For Further Information Contact:
Jean-Paul Bureaud
Executive Director, FAIR Canada
[email protected]



These press releases may also interest you

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 00:00
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...

28 avr 2024
Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...

28 avr 2024
A news report from CRI Online: In August 2023, the United Nations General Assembly (UNGA) adopted the resolution "International Decade of Sciences for Sustainable Development 2024-2033" (Sciences Decade). This resolution offers a distinctive...

27 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II between July 6, 2021 and November 8, 2022, both dates inclusive (the "Class...

27 avr 2024
Angara, the leading online DTC fine jewelry retail brand, has been honored with a Gold Stevie® Award for its "Celebrate with Color" campaign in the Marketing Campaign of the Year - Retail category in the 22nd Annual American Business...



News published on and distributed by: